Search

Anjana J Rao

from La Jolla, CA
Age ~72
Get Report
Related to:
Maya Bhardwaj, 34Vijay Bhardwaj, 71Shanti Rao, 67
Connected to:
Adil Rao, 32Ahmed Rao, 36Ajit Rao, 65Akanksha S Rao, 38Akhtar Rao, 52Akshata Rao, 37Aman Rao, 38Amar A Rao, 70Ambarish R Rao, 37Amruta Rao, 38

Anjana Rao Phones & Addresses

  • La Jolla, CA
  • 19 Agassiz St, Cambridge, MA 02140 (617) 864-6882
  • 19 Agassiz St APT 31, Cambridge, MA 02140

Work

Company: Bank of america - Waltham, MA Nov 2006 Position: Loan administrator i

Education

School / High School: West Chester University 1993 Specialities: Master of Business Administration in Marketing Management, Business Communications, Accounting

Skills

Typing • data entry • Excel • Word • Quickbooks

Resumes

Resumes

Anjana Rao Photo 1

Professor And Division Head

View page
Industry:
Research
Work:
La Jolla Institute For Immunology
Professor and Division Head
Harvard Medical School 1995 - 2010
Professor and Senior Investigator
Dana-Farber Cancer Institute 1993 - 1995
Associate Professor
Education:
Harvard University 1978
Doctorates, Doctor of Philosophy, Biophysics, Philosophy P.g. College of Law, Basheerbagh 1972
Master of Science, Masters, Physics P.g. College of Law, Basheerbagh 1970
Bachelors, Bachelor of Science
Anjana Rao Photo 2

Anjana Rao

View page
Anjana Rao Photo 3

Anjana Rao

View page
Anjana Rao Photo 4

Anjana Rao

View page
Anjana Rao Photo 5

Anjana Rao

View page
Anjana Rao Photo 6

Anjana Rao

View page
Anjana Rao Photo 7

Anjana Rao Natick, MA

View page
Work:
Bank of America
Waltham, MA
Nov 2006 to May 2008
Loan Administrator I
JP Morgan Chase
Boston, MA
Jun 2006 to Oct 2006
Fund Accountant
PFPC
Westborough, MA
Mar 2004 to Jun 2006
Investment Accountant I
Metropolitan Insurance Company
King of Prussia, PA
Mar 2003 to Mar 2004
Customer service, data entry, assigned adjusters
Education:
West Chester University
1993
Master of Business Administration in Marketing Management, Business Communications, Accounting
University of California, Berkeley
Berkeley, CA
1990
Bachelor of Science in Sciences
Skills:
Typing, data entry, Excel, Word, Quickbooks

Business Records

Name / Title
Company / Classification
Phones & Addresses
Anjana Rao
Owner
Anjana Rao
Noncommercial Research Organization
200 Longwood Ave, Boston, MA 02115

Publications

Us Patents

Specific Inhibitors Of Nfat Activation By Calcineurin And Their Use In Treating Immune-Related Diseases

View page
US Patent:
7084241, Aug 1, 2006
Filed:
Jan 31, 2002
Appl. No.:
10/066151
Inventors:
Patrick G. Hogan - Cambridge MA, US
Anjana Rao - Cambridge MA, US
Jose Aramburu - Boston MA, US
Assignee:
The CBR Institute for Biomedical Research, Inc. - Boston MA
International Classification:
C07K 7/00
C07K 7/06
C07K 7/08
C07K 14/00
US Classification:
530300, 530324, 530326, 530328
Abstract:
Isolated peptide fragments of the conserved regulatory domain of NFAT protein capable of inhibiting protein—protein interaction between calcineurin and NFAT, or a biologically active analog thereof are described. Isolated polynucleotides and gene therapy vectors encoding such peptide fragments are also described. In addition, methods for treating immune-related diseases or conditions and methods for high throughput screening of candidate agents are described. Pharmaceutical compositions are also provided.

Specific Inhibitors Of Nfat Activation By Calcineurin And Their Use In Treating Immune-Related Diseases

View page
US Patent:
7816490, Oct 19, 2010
Filed:
Oct 28, 2008
Appl. No.:
12/260049
Inventors:
Patrick G. Hogan - Cambridge MA, US
Anjana Rao - Cambridge MA, US
Jose Aramburu - Boston MA, US
Assignee:
Immune Disease Institute, Inc. - Boston MA
International Classification:
C07K 7/00
C07K 7/06
C07K 7/08
C07K 14/00
US Classification:
530330, 530324, 530326, 530328
Abstract:
Isolated peptide fragments of the conserved regulatory domain of NFAT protein capable of inhibiting protein-protein interaction between calcineurin and NFAT, or a biologically active analog thereof are described. Isolated polynucleotides and gene therapy vectors encoding such peptide fragments are also described. In addition, methods for treating immune-related diseases or conditions and methods for high throughput screening of candidate agents are described. Pharmaceutical compositions are also provided.

Regulators Of Nfat And/Or Store-Operated Calcium Entry

View page
US Patent:
8048864, Nov 1, 2011
Filed:
Oct 8, 2009
Appl. No.:
12/575655
Inventors:
Anjana Rao - Cambridge MA, US
Patrick Hogan - Cambridge MA, US
Sonia Sharma - Framingham MA, US
Assignee:
Immune Disease Institute, Inc. - Boston MA
International Classification:
A61K 31/70
C07H 21/04
US Classification:
514 44, 536 245
Abstract:
Embodiments of the inventions relates to modulating NFAT activity, modulating store-operated Ca entry into a cell and treating and/or preventing hyperactivity or inappropriate immune response by inhibiting the expression or activities of proteins involved in the calcineurin/NFAT axis.

Regulators Of Nfat And/Or Store-Operated Calcium Entry

View page
US Patent:
8394778, Mar 12, 2013
Filed:
Oct 8, 2010
Appl. No.:
12/901195
Inventors:
Anjana Rao - Cambridge MA, US
Patrick Hogan - Cambridge MA, US
Sonia Sharma - Boston MA, US
Assignee:
Immune Disease Institute, Inc. - Boston MA
International Classification:
A61K 31/70
C07H 21/04
US Classification:
514 44, 536 245
Abstract:
Embodiments of the inventions relate to modulating NFAT activity, modulating store-operated Ca entry into a cell and treating and/or preventing hyperactivity or inappropriate immune response by inhibiting the expression or activities of proteins involved in the calcineurin/NFAT axis.

Regulators Of Nfat

View page
US Patent:
8399185, Mar 19, 2013
Filed:
Jan 5, 2007
Appl. No.:
12/160030
Inventors:
Anjana Rao - Cambridge MA, US
Stefan Feske - New York NY, US
Patrick Hogan - Cambridge MA, US
Yousang Gwack - Los Angeles CA, US
Assignee:
Immune Disease Institute, Inc. - Boston MA
International Classification:
C12Q 1/00
C12N 15/63
A01N 63/00
C07H 21/04
US Classification:
435 4, 435455, 424 9321, 536 235
Abstract:
Disclosed are methods of identifying an agent that modulates an NFAT regulator protein. One such method comprises contacting at least one test agent with a recombinant cell comprising at least one NFAT regulator protein or fragment or derivative thereof, assessing the effect of the test agent on an activity, interaction, expression, or binding to the NFAT regulator protein or fragment or derivative thereof, and identifying the test agent that has an effect on an activity, interaction, expression, or binding to the NFAT regulator protein or fragment or derivative thereof, whereby the identified test agent is characterized as an agent that modulates an NFAT regulator protein. Methods of identifying an agent that modulates intracellular calcium, methods to screen for an agent that modulates NFAT regulator function, methods to diagnose unexplained immunodeficiency in a subject, and methods for identifying an agent for treating or preventing a disease or disorder associated with a NFAT regulator protein or calcium signaling are also disclosed.

Anergy-Regulated Molecules

View page
US Patent:
20030064380, Apr 3, 2003
Filed:
Jan 29, 2002
Appl. No.:
10/058024
Inventors:
Anjana Rao - Cambridge MA, US
Michael Byrne - Brookline MA, US
Fernando Macian - Quincy MA, US
Assignee:
The Center For Blood Research, Inc. - Boston MA
International Classification:
C12Q001/68
G01N033/53
G01N033/543
US Classification:
435/006000, 435/007100, 436/518000
Abstract:
Methods and compositions for the identification of novel targets for diagnosis, prognosis, therapeutic intervention and prevention of an immune disorder. In particular, the present invention is directed to the identification of novel targets which are anergy markers. The present invention is further directed to methods of high-throughput screening for test compounds capable of modulating the activity of proteins encoded by the novel targets. Moreover, the present invention is also directed to methods that can be used to assess the efficacy of test compounds and therapies for the ability to inhibit an immune disorder. Methods for determining the long term prognosis in a subject are also provided.

Specific Inhibitors Of Nfat Activation By Calcineurin And Their Use In Treating Immune-Related Diseases

View page
US Patent:
20040002117, Jan 1, 2004
Filed:
Feb 4, 2003
Appl. No.:
10/358052
Inventors:
Patrick Hogan - Cambridge MA, US
Anjana Rao - Cambridge MA, US
Jose Aramburu - Barcelona, ES
Michael Roehrl - Brookline MA, US
Gerhard Wagner - Chestnut Hill MA, US
Sunghyun Kang - Brookline MA, US
International Classification:
A61K031/00
G01N033/53
US Classification:
435/007100, 514/001000
Abstract:
Isolated peptide fragments of the conserved regulatory domain of NFAT protein capable of inhibiting protein-protein interaction between calcineurin and NFAT, or a biologically active analog thereof are described. Isolated polynucleotides and gene therapy vectors encoding such peptide fragments are also described. In addition, methods for treating immune-related diseases or conditions and methods for high throughput screening of candidate agents are described. Pharmaceutical compositions are also provided.

Specific Inhibitors Of Nfat Activation By Calcineurin And Their Use In Treating Immune-Related Diseases

View page
US Patent:
20070042403, Feb 22, 2007
Filed:
Jun 23, 2006
Appl. No.:
11/474218
Inventors:
Patrick Hogan - Cambridge MA, US
Anjana Rao - Cambridge MA, US
Jose Aramburu - Boston MA, US
International Classification:
C12Q 1/68
G01N 33/53
A61K 38/17
C07K 14/71
C07H 21/04
C12P 21/06
US Classification:
435006000, 435007100, 435069100, 435320100, 435325000, 514012000, 514044000, 530350000, 536023500
Abstract:
Isolated peptide fragments of the conserved regulatory domain of NFAT protein capable of inhibiting protein-protein interaction between calcineurin and NFAT, or a biologically active analog thereof are described. Isolated polynucleotides and gene therapy vectors encoding such peptide fragments are also described. In addition, methods for treating immune-related diseases or conditions and methods for high throughput screening of candidate agents are described. Pharmaceutical compositions are also provided.
Control profile
Anjana J Rao from La Jolla, CA, age ~72 Get Report